Saturday, 29 September 2018

Saturday, September 29, 2018

7.30-8.15

Morning “networking”-walk

Pregnancy registries in rheumatic diseases

Experts:
Christina Chambers (La Jolla, United States)
Frauke Förger (Bern, Switzerland)
Christina Wallenius (Trondheim, Norway)

9.00-10.40

Anti-rheumatic drugs in reproduction

Sopra Grande

Chairs:
Christina Chambers (La Jolla, United States)
Monika Østensen (Trondheim, Norway)

9.00

Drug safety in pregnancy: utopia or achievable prospect
Christof Schaefer (Berlin, Germany)

9.20

Biologics in pregnancy and lactation
Christina Chambers (La Jolla, United States)

9.40

The use of antirheumatic drugs in male patients planning a family
Monika Østensen (Trondheim, Norway)

Abstracts

10.00

Peri-conception paternal exposure to methotrexate: a systematic review
Julia Flint (London, United Kingdom)

10.10

Is antenatal prednisone exposure associated with chronically elevated cortisol levels in children born to women with rheumatoid arthritis?
Hilal Ince-Askan (Rotterdam, The Netherlands)

10.20

Demyelinating Disorders in RA Offspring Exposed to TNF Inhibitors
Evelyne Vinet (Montreal, Canada)

10.30

Low risk of flares and adverse pregnancy outcomes in women with Rheumatoid Arthritis who continue TNF inhibitors during pregnancy
Isabell Haase (Duesseldorf, Germany)

10.40 - 11.00

Coffee break

11.00-12.30

Contraception, Fertility, Reproduction

Sopra Grande

Chairs:
Marianne Wallenius (Trondheim, Norway)
Michael von Wolff (Bern, Switzerland)

11.00

Contraception in rheumatic diseases
Petra Stute (Bern, Switzerland)

11.20

Fertility in women with rheumatic diseases
Marianne Wallenius (Trondheim, Norway)

11.40

Assisted reproduction in rheumatic diseases
Michael von Wolff (Bern, Switzerland)

Abstracts

12.00

Combined Hormonal Contraception use in SLE Women with and without Medical Contraindications
Arielle Mendel (Montreal, Canada) 

12.10

Systemic lupus erythematosus, antiphospholipid syndrome and in vitro fertilization: a multicentric, international survey
Elena Gibbone (Baracaldo, Spain)

12.20

Non steroidal anti-inflammatory drugs (NSAID) such as ibuprofen affect follicular physiology but not fertility
Michael von Wolff (Bern, Switzerland)

12.30-13.00

Closing session

Sopra Grande

Chairs:
Frauke Förger (Bern, Switzerland)
Peter Villiger (Bern, Switzerland)

12.30

Last but not least: Effect of hormones on rheumatic diseases
Maurizio Cutolo (Genova, Italy)

12.50

Concluding remarks
Frauke Förger (Bern, Switzerland)
Peter Villiger (Bern, Switzerland)

The timing and the programme indicated maybe subject to change.